GLP_1 RA Ultrasound Study

Cincinnati Children's Hospital Medical Center

Status: Invitation-only

Conditions: Glucagon Like Peptide-1 (GLP-1; Diabetes; Delayed Gastric Emptying; Morbid Obesity; Risk of Aspiration

Treatments: Diagnostic Test: Point of Care Gastric Ultrasound; Drug: Glucagon-Like Peptide-1 receptor agonists

Study type: Observational

Funder types: Other

Identifiers

NCT06581120

2024-0304

Details and patient eligibility

About

The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.

Enrollment: 100 estimated patients

Sex: All

Ages: 10 to 25 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Body Mass Index over 35
• Type 2 Diabetes
• Currently taking GLP01 RA agonist (for GLP 1 group)
• Not taking GLP-1 RA agonist (for control group)

Exclusion criteria

• Diagnosis of gastroparesis
• patient refusal to participate
• Previous gastric bypass or any other gastric surgery
• Currently on peritoneal dialysis
• Abdominal pathology
• Gastro-intestinal obstruction
• Pregnancy

Trial design

100 participants in 2 patient groups

GLP-1

Description:

Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.

Treatment:

Drug: Glucagon-Like Peptide-1 receptor agonists

Diagnostic Test: Point of Care Gastric Ultrasound

Control

Description:

Individuals not taking GLP-1 who have a surgery scheduled with Cincinnati Children's Hospital same day surgery or endocrinology clinic and will receive a point of care gastric ultrasound.

Treatment:

Diagnostic Test: Point of Care Gastric Ultrasound